Kathryn Gregory - Net Worth and Insider Trading
Kathryn Gregory Net Worth
The estimated net worth of Kathryn Gregory is at least $18,080 dollars as of 2025-05-05. Kathryn Gregory is the Director of Longevity Health Holdings Inc and owns about 84,757 shares of Longevity Health Holdings Inc (XAGE) stock worth over $13,985. Kathryn Gregory is also the SVP, Chief Business Officer of Rein Therapeutics Inc and owns about 2,250 shares of Rein Therapeutics Inc (RNTX) stock worth over $4,095. Details can be seen in Kathryn Gregory's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathryn Gregory has not made any transactions after 2024-09-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Kathryn Gregory
Kathryn Gregory Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kathryn Gregory owns 2 companies in total, including Rein Therapeutics Inc (RNTX) , and Longevity Health Holdings Inc (XAGE) .
Click here to see the complete history of Kathryn Gregory’s form 4 insider trades.
Insider Ownership Summary of Kathryn Gregory
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
RNTX | Rein Therapeutics Inc | 2019-08-13 | SVP & Chief Business Officer |
XAGE | Longevity Health Holdings Inc | 2024-09-06 | director |
Kathryn Gregory Latest Holdings Summary
Kathryn Gregory currently owns a total of 2 stocks. Among these stocks, Kathryn Gregory owns 84,757 shares of Longevity Health Holdings Inc (XAGE) as of September 6, 2024, with a value of $13,985 and a weighting of 77.35%. Kathryn Gregory also owns 2,250 shares of Rein Therapeutics Inc (RNTX) as of August 13, 2019, with a value of $4,095 and a weighting of 22.65%.
Latest Holdings of Kathryn Gregory
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XAGE | Longevity Health Holdings Inc | 2024-09-06 | 84,757 | 0.17 | 13,985 |
RNTX | Rein Therapeutics Inc | 2019-08-13 | 2,250 | 1.82 | 4,095 |
Holding Weightings of Kathryn Gregory
Kathryn Gregory Form 4 Trading Tracker
According to the SEC Form 4 filings, Kathryn Gregory has made a total of 9 transactions in Longevity Health Holdings Inc (XAGE) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Longevity Health Holdings Inc is the acquisition of 1,260 shares on September 6, 2024, which cost Kathryn Gregory around $643.
According to the SEC Form 4 filings, Kathryn Gregory has made a total of 0 transactions in Rein Therapeutics Inc (RNTX) over the past 5 years. The most-recent trade in Rein Therapeutics Inc is the acquisition of 2,250 shares on August 13, 2019, which cost Kathryn Gregory around $29,250.
Insider Trading History of Kathryn Gregory
- 1
Kathryn Gregory Trading Performance
GuruFocus tracks the stock performance after each of Kathryn Gregory's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathryn Gregory is -41.76%. GuruFocus also compares Kathryn Gregory's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathryn Gregory within 3 months outperforms 0 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kathryn Gregory's insider trading performs compared to the benchmark.
Performance of Kathryn Gregory
Kathryn Gregory Ownership Network
Ownership Network List of Kathryn Gregory
Ownership Network Relation of Kathryn Gregory

Kathryn Gregory Owned Company Details
What does Rein Therapeutics Inc do?
Who are the key executives at Rein Therapeutics Inc?
Kathryn Gregory is the SVP & Chief Business Officer of Rein Therapeutics Inc. Other key executives at Rein Therapeutics Inc include See Remarks James Brian Windsor , See Remarks Susan L. Drexler , and 10 percent owner Muneer A Satter .
Rein Therapeutics Inc (RNTX) Insider Trades Summary
Over the past 18 months, Kathryn Gregory made no insider transaction in Rein Therapeutics Inc (RNTX). Other recent insider transactions involving Rein Therapeutics Inc (RNTX) include a net sale of 95,059 shares made by , and a net purchase of 5,701 shares made by James Brian Windsor .
In summary, during the past 3 months, insiders sold 0 shares of Rein Therapeutics Inc (RNTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 95,059 shares of Rein Therapeutics Inc (RNTX) were sold and 5,701 shares were bought by its insiders, resulting in a net sale of 89,358 shares.
Rein Therapeutics Inc (RNTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rein Therapeutics Inc Insider Transactions
Kathryn Gregory Mailing Address
Above is the net worth, insider trading, and ownership report for Kathryn Gregory. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kathryn Gregory's mailing address is: Wilton Ct 06897.